ischaemic stroke

Biopharmaceutical company Basking Biosciences has revealed positive Phase I study results for its reversible thrombolytic therapeutic for ischaemic stroke.  The company’s novel von Willebrand Factor (vWF)-targeting thrombolytic agent, BB-031 demonstrated safety and tolerability following a single intravenous dose.   The study results were presented at the American Heart Association International Stroke Conference (ISC) 2023 in Dallas, […]

Getting an annual flu shot may be associated with a lower risk of stroke, Spanish researchers have claimed. The findings, from a study conducted at the University of Alcalá in Madrid, have been published in the journal Neurology. The observational study suggests that those who have a flu shot have a lower risk of stroke. […]